The role of corticotropin-releasing factor and corticosterone in stress- and cocaine-induced relapse to cocaine seeking in rats.
Identifieur interne : 001F42 ( Main/Corpus ); précédent : 001F41; suivant : 001F43The role of corticotropin-releasing factor and corticosterone in stress- and cocaine-induced relapse to cocaine seeking in rats.
Auteurs : S. Erb ; Y. Shaham ; J. StewartSource :
- The Journal of neuroscience : the official journal of the Society for Neuroscience [ 0270-6474 ] ; 1998.
English descriptors
- KwdEn :
- Adrenal Glands (physiology), Adrenalectomy (MeSH), Animals (MeSH), Catheterization, Peripheral (MeSH), Cocaine (pharmacology), Corticosterone (pharmacology), Corticosterone (physiology), Corticotropin-Releasing Hormone (analogs & derivatives), Corticotropin-Releasing Hormone (pharmacology), Corticotropin-Releasing Hormone (physiology), Electroshock (MeSH), Male (MeSH), Rats (MeSH), Recurrence (MeSH), Reinforcement, Psychology (MeSH), Self Administration (MeSH), Stress, Physiological (physiopathology).
- MESH :
- chemical , analogs & derivatives : Corticotropin-Releasing Hormone.
- chemical , pharmacology : Cocaine, Corticosterone, Corticotropin-Releasing Hormone.
- physiology : Adrenal Glands, Corticosterone, Corticotropin-Releasing Hormone.
- physiopathology : Stress, Physiological.
- Adrenalectomy, Animals, Catheterization, Peripheral, Electroshock, Male, Rats, Recurrence, Reinforcement, Psychology, Self Administration.
Abstract
We have shown previously that footshock stress and priming injections of cocaine reinstate cocaine seeking in rats after prolonged drug-free periods (Erb et al., 1996). Here we examined the role of brain corticotropin-releasing factor (CRF) and the adrenal hormone corticosterone in stress- and cocaine-induced reinstatement of cocaine seeking in rats. The ability of footshock stress and priming injections of cocaine to induce relapse to cocaine seeking was studied after intracerebroventricular infusions of the CRF receptor antagonist D-Phe CRF12-41, after adrenalectomy, and after adrenalectomy with corticosterone replacement. Rats were allowed to self-administer cocaine (1.0 mg/kg/infusion, i.v) for 3 hr daily for 10-14 d and were then placed on an extinction schedule during which saline was substituted for cocaine. Tests for reinstatement were given after intermittent footshock (10 min; 0.5 mA) and after priming injections of saline and cocaine (20 mg/kg, i.p.). Footshock reinstated cocaine seeking in both intact animals and animals with corticosterone replacement but not in adrenalectomized animals. The CRF receptor antagonist D-Phe CRF12-41 blocked footshock-induced reinstatement at all doses tested in both intact animals and animals with corticosterone replacement. Reinstatement by priming injections of cocaine was only minimally attenuated by adrenalectomy and by pretreatment with D-Phe CRF12-41. These data suggest that brain CRF plays a critical role in stress-induced, but only a modulatory role in cocaine-induced, reinstatement of cocaine seeking. Furthermore, the data show that although reinstatement of cocaine seeking by footshock stress requires minimal, basal, levels of corticosterone, stress-induced increases in corticosterone do not play a role in this effect.
PubMed: 9651233
PubMed Central: PMC6793509
Links to Exploration step
pubmed:9651233Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">The role of corticotropin-releasing factor and corticosterone in stress- and cocaine-induced relapse to cocaine seeking in rats.</title>
<author><name sortKey="Erb, S" sort="Erb, S" uniqKey="Erb S" first="S" last="Erb">S. Erb</name>
<affiliation><nlm:affiliation>Center for Studies in Behavioral Neurobiology, Department of Psychology, Concordia University, Montreal, Quebec, Canada, H3G 1M8.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Shaham, Y" sort="Shaham, Y" uniqKey="Shaham Y" first="Y" last="Shaham">Y. Shaham</name>
</author>
<author><name sortKey="Stewart, J" sort="Stewart, J" uniqKey="Stewart J" first="J" last="Stewart">J. Stewart</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="1998">1998</date>
<idno type="RBID">pubmed:9651233</idno>
<idno type="pmid">9651233</idno>
<idno type="pmc">PMC6793509</idno>
<idno type="wicri:Area/Main/Corpus">001F42</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">001F42</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">The role of corticotropin-releasing factor and corticosterone in stress- and cocaine-induced relapse to cocaine seeking in rats.</title>
<author><name sortKey="Erb, S" sort="Erb, S" uniqKey="Erb S" first="S" last="Erb">S. Erb</name>
<affiliation><nlm:affiliation>Center for Studies in Behavioral Neurobiology, Department of Psychology, Concordia University, Montreal, Quebec, Canada, H3G 1M8.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Shaham, Y" sort="Shaham, Y" uniqKey="Shaham Y" first="Y" last="Shaham">Y. Shaham</name>
</author>
<author><name sortKey="Stewart, J" sort="Stewart, J" uniqKey="Stewart J" first="J" last="Stewart">J. Stewart</name>
</author>
</analytic>
<series><title level="j">The Journal of neuroscience : the official journal of the Society for Neuroscience</title>
<idno type="ISSN">0270-6474</idno>
<imprint><date when="1998" type="published">1998</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adrenal Glands (physiology)</term>
<term>Adrenalectomy (MeSH)</term>
<term>Animals (MeSH)</term>
<term>Catheterization, Peripheral (MeSH)</term>
<term>Cocaine (pharmacology)</term>
<term>Corticosterone (pharmacology)</term>
<term>Corticosterone (physiology)</term>
<term>Corticotropin-Releasing Hormone (analogs & derivatives)</term>
<term>Corticotropin-Releasing Hormone (pharmacology)</term>
<term>Corticotropin-Releasing Hormone (physiology)</term>
<term>Electroshock (MeSH)</term>
<term>Male (MeSH)</term>
<term>Rats (MeSH)</term>
<term>Recurrence (MeSH)</term>
<term>Reinforcement, Psychology (MeSH)</term>
<term>Self Administration (MeSH)</term>
<term>Stress, Physiological (physiopathology)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="analogs & derivatives" xml:lang="en"><term>Corticotropin-Releasing Hormone</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Cocaine</term>
<term>Corticosterone</term>
<term>Corticotropin-Releasing Hormone</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en"><term>Adrenal Glands</term>
<term>Corticosterone</term>
<term>Corticotropin-Releasing Hormone</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Stress, Physiological</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adrenalectomy</term>
<term>Animals</term>
<term>Catheterization, Peripheral</term>
<term>Electroshock</term>
<term>Male</term>
<term>Rats</term>
<term>Recurrence</term>
<term>Reinforcement, Psychology</term>
<term>Self Administration</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">We have shown previously that footshock stress and priming injections of cocaine reinstate cocaine seeking in rats after prolonged drug-free periods (Erb et al., 1996). Here we examined the role of brain corticotropin-releasing factor (CRF) and the adrenal hormone corticosterone in stress- and cocaine-induced reinstatement of cocaine seeking in rats. The ability of footshock stress and priming injections of cocaine to induce relapse to cocaine seeking was studied after intracerebroventricular infusions of the CRF receptor antagonist D-Phe CRF12-41, after adrenalectomy, and after adrenalectomy with corticosterone replacement. Rats were allowed to self-administer cocaine (1.0 mg/kg/infusion, i.v) for 3 hr daily for 10-14 d and were then placed on an extinction schedule during which saline was substituted for cocaine. Tests for reinstatement were given after intermittent footshock (10 min; 0.5 mA) and after priming injections of saline and cocaine (20 mg/kg, i.p.). Footshock reinstated cocaine seeking in both intact animals and animals with corticosterone replacement but not in adrenalectomized animals. The CRF receptor antagonist D-Phe CRF12-41 blocked footshock-induced reinstatement at all doses tested in both intact animals and animals with corticosterone replacement. Reinstatement by priming injections of cocaine was only minimally attenuated by adrenalectomy and by pretreatment with D-Phe CRF12-41. These data suggest that brain CRF plays a critical role in stress-induced, but only a modulatory role in cocaine-induced, reinstatement of cocaine seeking. Furthermore, the data show that although reinstatement of cocaine seeking by footshock stress requires minimal, basal, levels of corticosterone, stress-induced increases in corticosterone do not play a role in this effect.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">9651233</PMID>
<DateCompleted><Year>1998</Year>
<Month>07</Month>
<Day>27</Day>
</DateCompleted>
<DateRevised><Year>2019</Year>
<Month>12</Month>
<Day>10</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Print">0270-6474</ISSN>
<JournalIssue CitedMedium="Print"><Volume>18</Volume>
<Issue>14</Issue>
<PubDate><Year>1998</Year>
<Month>Jul</Month>
<Day>15</Day>
</PubDate>
</JournalIssue>
<Title>The Journal of neuroscience : the official journal of the Society for Neuroscience</Title>
<ISOAbbreviation>J Neurosci</ISOAbbreviation>
</Journal>
<ArticleTitle>The role of corticotropin-releasing factor and corticosterone in stress- and cocaine-induced relapse to cocaine seeking in rats.</ArticleTitle>
<Pagination><MedlinePgn>5529-36</MedlinePgn>
</Pagination>
<Abstract><AbstractText>We have shown previously that footshock stress and priming injections of cocaine reinstate cocaine seeking in rats after prolonged drug-free periods (Erb et al., 1996). Here we examined the role of brain corticotropin-releasing factor (CRF) and the adrenal hormone corticosterone in stress- and cocaine-induced reinstatement of cocaine seeking in rats. The ability of footshock stress and priming injections of cocaine to induce relapse to cocaine seeking was studied after intracerebroventricular infusions of the CRF receptor antagonist D-Phe CRF12-41, after adrenalectomy, and after adrenalectomy with corticosterone replacement. Rats were allowed to self-administer cocaine (1.0 mg/kg/infusion, i.v) for 3 hr daily for 10-14 d and were then placed on an extinction schedule during which saline was substituted for cocaine. Tests for reinstatement were given after intermittent footshock (10 min; 0.5 mA) and after priming injections of saline and cocaine (20 mg/kg, i.p.). Footshock reinstated cocaine seeking in both intact animals and animals with corticosterone replacement but not in adrenalectomized animals. The CRF receptor antagonist D-Phe CRF12-41 blocked footshock-induced reinstatement at all doses tested in both intact animals and animals with corticosterone replacement. Reinstatement by priming injections of cocaine was only minimally attenuated by adrenalectomy and by pretreatment with D-Phe CRF12-41. These data suggest that brain CRF plays a critical role in stress-induced, but only a modulatory role in cocaine-induced, reinstatement of cocaine seeking. Furthermore, the data show that although reinstatement of cocaine seeking by footshock stress requires minimal, basal, levels of corticosterone, stress-induced increases in corticosterone do not play a role in this effect.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Erb</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
<AffiliationInfo><Affiliation>Center for Studies in Behavioral Neurobiology, Department of Psychology, Concordia University, Montreal, Quebec, Canada, H3G 1M8.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Shaham</LastName>
<ForeName>Y</ForeName>
<Initials>Y</Initials>
</Author>
<Author ValidYN="Y"><LastName>Stewart</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
<PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>J Neurosci</MedlineTA>
<NlmUniqueID>8102140</NlmUniqueID>
<ISSNLinking>0270-6474</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C113202">phenylalanyl corticotropin-releasing factor (12-41)</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>9015-71-8</RegistryNumber>
<NameOfSubstance UI="D003346">Corticotropin-Releasing Hormone</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>I5Y540LHVR</RegistryNumber>
<NameOfSubstance UI="D003042">Cocaine</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>W980KJ009P</RegistryNumber>
<NameOfSubstance UI="D003345">Corticosterone</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000311" MajorTopicYN="N">Adrenal Glands</DescriptorName>
<QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000315" MajorTopicYN="N">Adrenalectomy</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002406" MajorTopicYN="N">Catheterization, Peripheral</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003042" MajorTopicYN="N">Cocaine</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003345" MajorTopicYN="N">Corticosterone</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
<QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003346" MajorTopicYN="N">Corticotropin-Releasing Hormone</DescriptorName>
<QualifierName UI="Q000031" MajorTopicYN="Y">analogs & derivatives</QualifierName>
<QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
<QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004597" MajorTopicYN="N">Electroshock</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012008" MajorTopicYN="N">Recurrence</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012054" MajorTopicYN="N">Reinforcement, Psychology</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012646" MajorTopicYN="N">Self Administration</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D013312" MajorTopicYN="N">Stress, Physiological</DescriptorName>
<QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1998</Year>
<Month>7</Month>
<Day>3</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>1998</Year>
<Month>7</Month>
<Day>3</Day>
<Hour>0</Hour>
<Minute>1</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>1998</Year>
<Month>7</Month>
<Day>3</Day>
<Hour>0</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">9651233</ArticleId>
<ArticleId IdType="pmc">PMC6793509</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Physiol Behav. 1979 May;22(5):867-70</Citation>
<ArticleIdList><ArticleId IdType="pubmed">504396</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Neurosci. 1995 Aug;15(8):5439-47</Citation>
<ArticleIdList><ArticleId IdType="pubmed">7643193</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Psychopharmacology (Berl). 1989;97(1):59-64</Citation>
<ArticleIdList><ArticleId IdType="pubmed">2496428</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Brain Res Brain Res Rev. 1990 May-Aug;15(2):71-100</Citation>
<ArticleIdList><ArticleId IdType="pubmed">1980834</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Neurochem. 1993 Feb;60(2):602-12</Citation>
<ArticleIdList><ArticleId IdType="pubmed">7678287</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Med Chem. 1997 May 23;40(11):1749-54</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9171885</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 1991 Mar 15;88(6):2088-92</Citation>
<ArticleIdList><ArticleId IdType="pubmed">2006148</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Psychopharmacology (Berl). 1997 Aug;132(3):289-95</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9292629</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Neuroendocrinology. 1996 Nov;64(5):337-48</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8930934</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Arch Gen Psychiatry. 1986 Aug;43(8):733-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">3729667</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Science. 1996 Mar 15;271(5255):1586-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8599115</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Psychopharmacology (Berl). 1996 Dec;128(4):408-12</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8986011</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Psychopharmacology (Berl). 1995 Jun;119(3):334-41</Citation>
<ArticleIdList><ArticleId IdType="pubmed">7675970</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Ann N Y Acad Sci. 1993 Oct 29;697:142-54</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8257007</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Neurosci. 1994 May;14(5 Pt 1):2724-31</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8182438</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Psychopharmacology (Berl). 1995 Sep;121(2):150-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8545519</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Crit Rev Neurobiol. 1996;10(2):155-68</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8971127</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Neuron. 1996 May;16(5):893-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8630244</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Ann N Y Acad Sci. 1994 Oct 31;739:176-84</Citation>
<ArticleIdList><ArticleId IdType="pubmed">7832471</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Brain Res. 1993 Mar 26;606(2):181-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8490714</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Annu Rev Pharmacol Toxicol. 1993;33:353-82</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8494344</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 1996 Aug 6;93(16):8716-20</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8710937</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Neurosci. 1997 Jan 1;17(1):401-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8987765</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Pharmacol Exp Ther. 1997 Jun;281(3):1401-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9190876</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Regul Pept. 1995 Oct 20;59(2):183-92</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8584753</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Neurosci. 1998 Mar 1;18(5):1848-59</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9465009</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Psychopharmacology (Berl). 1981;75(2):134-43</Citation>
<ArticleIdList><ArticleId IdType="pubmed">6798603</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Brain Res. 1994 Mar 21;640(1-2):105-12</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8004437</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Neurosci. 1997 Apr 1;17(7):2605-14</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9065520</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Brain Res. 1992 Feb 7;571(2):204-11</Citation>
<ArticleIdList><ArticleId IdType="pubmed">1319266</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Stud Alcohol. 1992 Jul;53(4):357-63</Citation>
<ArticleIdList><ArticleId IdType="pubmed">1619930</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Comp Neurol. 1989 Jul 22;285(4):413-35</Citation>
<ArticleIdList><ArticleId IdType="pubmed">2569487</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Brain Res. 1994 Sep 19;657(1-2):141-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">7820612</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Ann N Y Acad Sci. 1993 Oct 29;697:173-88</Citation>
<ArticleIdList><ArticleId IdType="pubmed">7903030</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Behav Pharmacol. 1995 Jan;6(1):74-80</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11224314</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Annu Rev Pharmacol Toxicol. 1996;36:359-78</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8725394</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Brain Res. 1988 Aug 9;457(2):287-94</Citation>
<ArticleIdList><ArticleId IdType="pubmed">3219557</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Brain Res. 1994 Sep 26;658(1-2):259-64</Citation>
<ArticleIdList><ArticleId IdType="pubmed">7834350</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Brain Res. 1995 Mar 27;675(1-2):89-97</Citation>
<ArticleIdList><ArticleId IdType="pubmed">7796157</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Pharmacol Biochem Behav. 1984 Jun;20(6):917-23</Citation>
<ArticleIdList><ArticleId IdType="pubmed">6463075</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Brain Res. 1996 May 25;722(1-2):145-52</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8813360</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Neuropsychopharmacology. 1997 Feb;16(2):156-61</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9015798</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Psychopharmacology (Berl). 1990;100(3):355-60</Citation>
<ArticleIdList><ArticleId IdType="pubmed">2315433</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Neuroendocrinology. 1984 May;38(5):411-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">6328347</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Psychopharmacology (Berl). 1998 May;137(2):184-90</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9630005</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Pharmacol Biochem Behav. 1994 May;48(1):217-21</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8029293</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Psychopharmacology (Berl). 1996 Jun;125(4):385-91</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8826544</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Brain Res. 1992 Aug 28;589(1):154-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">1330207</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/AutomedicationFrancoV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001F42 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 001F42 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= AutomedicationFrancoV1 |flux= Main |étape= Corpus |type= RBID |clé= pubmed:9651233 |texte= The role of corticotropin-releasing factor and corticosterone in stress- and cocaine-induced relapse to cocaine seeking in rats. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/RBID.i -Sk "pubmed:9651233" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd \ | NlmPubMed2Wicri -a AutomedicationFrancoV1
![]() | This area was generated with Dilib version V0.6.38. | ![]() |